Top Stories

Latest News

Why Every Portfolio Needs The World's Most Enduring Asset

1751466725 from SALPHA

No description available

Pepsi: Buyer Beware, The Warning Signs Are There

1751461783 from SALPHA

No description available

Collect 7% From July's Top Income Pick: DFP

1751456100 from SALPHA

No description available

Dividend Panic Coming? 3 Strong Buys Before The Crowd Wakes Up

1751455800 from SALPHA

No description available

Who Wants To Be A Billionaire?

1751454344 from SALPHA

No description available

EV Wars: Who's The Winner?

1751454000 from SALPHA

No description available

Intel's AI-Fueled Comeback - Why The Chip Giant Is Back In The Game

1751442859 from SALPHA

No description available

UnitedHealth: Cheap, But Is It Worth It?

1751437883 from SALPHA

No description available

What Makes ServiceNow A Rare Tech Compounder In A Noisy Market

1751435738 from SALPHA

No description available

British American Tobacco: Heated Tobacco Stumbles, But Oral Nicotine Is Catching Fire

1751433369 from SALPHA

No description available

HOOY: 100% Dividend Yield Isn't Worth Entering At The Highs

1751417723 from SALPHA

No description available

First-Half 2025 Stock Review And Second-Half Picks

1751400938 from SALPHA

No description available

Palantir: Let's Talk About The Elephant In The Room (Valuation)

1751388918 from SALPHA

No description available

Macro Insights From June 2025: Oil & Trade Wars, Market Peaks, & Stagflation Fears

1751385600 from SALPHA

No description available

AST SpaceMobile: A Winner In The Long Run

1751374480 from SALPHA

No description available

Build Your Own Alternative Income Portfolio - Billionaire Style

1751369400 from SALPHA

No description available

Market Halftime Show Features New Records

1751369018 from SALPHA

No description available

3 Reasons To Avoid Dividend Stocks In H2 2025

1751368200 from SALPHA

No description available

Archer: My Bullish Bet's Paying Off

1751365466 from SALPHA

No description available

Hims & Hers: My Main Concern Isn't Weight Loss, But Valuation (Rating Downgrade)

1751354218 from SALPHA

No description available

AMD: OpenAI Endorsement Is A Game Changer

1751352205 from SALPHA

No description available

Bristol-Myers Squibb: Great Dividend But Questionable Growth Prospects

1751351729 from SALPHA

No description available

BYD Looks Like A Beast, But There Are Reasons To Wait

1751351607 from SALPHA

No description available

Abercrombie & Fitch: Two Steps Forward, Two Steps Back

1751349252 from SALPHA

No description available

Chime: Path To Strong Upside

1751346319 from SALPHA

No description available

Alexandria Real Estate: Behind Fantastic Dividends, 3 Key Facts To Understand Its Resilience

1751343405 from SALPHA

No description available

AMD: The Inflection Moment May Have Arrived

1751332871 from SALPHA

No description available

American Airlines: As Speculative As It Gets

1751306607 from SALPHA

No description available

Banco Macro: A Logical Pause After The Enthusiasm

1751303100 from SALPHA

No description available

Nvidia: Why I Am Aggressively Accumulating At All-Time High

1751300794 from SALPHA

No description available

Liberty Broadband May Be The Biggest Winner Of The Charter-Cox Merger

1751298409 from SALPHA

No description available

Apple: Think Different? Time To Think Again About Innovation

1751296783 from SALPHA

No description available

Collect Massive Preferred Stock Income For Your Retirement: PFFA

1751283300 from SALPHA

No description available

This Changes Everything: One Of The Most Important Shifts For Dividend Investors

1751283000 from SALPHA

No description available

Nebius Group: My Biggest AI Portfolio Position

1751278018 from SALPHA

No description available

Stocks At Critical Juncture As Tariff Risks Return And AI Surpasses Key Threshold

1751277701 from SALPHA

No description available

ARDC: The Worst Is Likely Over, But Still Not A Buy (Rating Upgrade)

1751254985 from SALPHA

No description available

Alphabet Is Building An AI Empire You'll Want To Be In

1751254111 from SALPHA

No description available

UTF: Explosive Run Looks Unlikely To Stop

1751215946 from SALPHA

No description available

Income Method: The Rule Of 42

1751206500 from SALPHA

No description available

Bristol-Myers Squibb: You Might Wish You Bought More Now (Upgrade)

1751202000 from SALPHA

No description available

3 Fast-Growing Stocks Disrupting A Trillion-Dollar Industry

1751200200 from SALPHA

No description available

UnitedHealth: Pivotal Changes Underway

1751182042 from SALPHA

No description available

Gravity's Global Rollout Turns A Single Franchise Into A Deep Value Play

1751178800 from SALPHA

No description available

Dividend Powerhouses: Top 5 Stocks With Yields Over 4%

1751126400 from SALPHA

No description available

Equinix: The Real Estate Life Cycle Strikes Again

1751117400 from SALPHA

No description available

Among MLPs, MLPX Is The Most Promising Candidate Going Forward

1751117040 from SALPHA

No description available

Embraer: Good Story, But The Market Has Already Paid For It (Rating Downgrade)

1751103989 from SALPHA

No description available

Coinbase Is Implicitly 'Eating Financial Services' And To That, I Say, Bon Appétit!

1751101670 from SALPHA

No description available

Lucid: Tesla Stumbles And Tariffs Bode Well (Mostly)

1751091240 from SALPHA

No description available